TuHURA Biosciences (HURA) Operating Leases (2024 - 2026)

TuHURA Biosciences' Operating Leases history runs 3 years deep, the most recent figure standing at $250075.0 for Q1 2026.

• On a quarterly basis, Operating Leases changed N/A year-over-year to $250075.0 in Q1 2026; TTM through Mar 2026 was $250075.0, a N/A change from a year earlier, with the FY2025 full-year figure at $303627.0, up 611.1% from the prior year.
• Operating Leases fell to $250075.0 in Q1 2026 per HURA's latest filing, from $303627.0 in the prior quarter.
• Across five years, Operating Leases topped out at $303627.0 in Q4 2025 and bottomed at $42698.0 in Q4 2024.
• The 3-year median for Operating Leases is $250075.0 (2026), against an average of $198800.0.
• Biggest YoY gain for Operating Leases was 611.1% in 2025; the steepest drop was 611.1% in 2025.
• Year by year, Operating Leases stood at $42698.0 in 2024, then jumped by 611.1% to $303627.0 in 2025, then decreased by 17.64% to $250075.0 in 2026.
• Per Business Quant, the three latest HURA Operating Leases figures stand at $250075.0 (Q1 2026), $303627.0 (Q4 2025), and $42698.0 (Q4 2024).